Riluzole and other prognostic factors in ALS: a population-based registry study in Italy

ConclusionsIndependently from other prognostic factors, patients who received riluzole for a longer period of time survived longer, but further population based studies are needed to verify if long-tem use of riluzole prolongs survival.

Source: Journal of Neurology - February 5, 2018 Category: Neurology Source Type: research